GAM
RGNX icon

Gotham Asset Management’s Regenxbio RGNX Stock Holding History

Gotham Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,309
Closed -$276K – 1226
2022
Q1 		$276K Buy
+8,309
New +$231K 0.01% 970
2019
Q2 		– Sell
-20,169
Closed -$1.16M – 1260
2019
Q1 		$1.16M Sell
20,169
-1,679
-8% -$83.2K 0.02% 618
2018
Q4 		$917K Sell
21,848
-30,643
-58% -$1.8M 0.01% 652
2018
Q3 		$3.96M Buy
52,491
+22,763
+77% +$1.64M 0.05% 390
2018
Q2 		$2.13M Buy
+29,728
New +$1.42M 0.03% 465
2017
Q4 		– Sell
-10,470
Closed -$345K – 1040
2017
Q3 		$345K Buy
+10,470
New +$236K 0.01% 771

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Gotham Asset Management's RGNX Position: Q2 2022 in Review

Gotham Asset Management sold out of Regenxbio (RGNX) in Q2 2022, closing a stake of 8,309 shares — an estimated $276K sold.

Gotham Asset Management first reported a position in RGNX in Q3 2017 and held it in 6 quarters. The position peaked at $3.96M in Q3 2018. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.

  • Gotham Asset Management reported no remaining Regenxbio position as of Q2 2022 after selling out during the quarter.
  • Gotham Asset Management sold 8,309 Regenxbio shares in Q2 2022, an estimated $276K.
  • Gotham Asset Management first reported a position in Regenxbio in Q3 2017 and held it in 6 quarters.
  • Gotham Asset Management's Regenxbio position peaked at $3.96M in Q3 2018.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.

Based on Gotham Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.